Reinhart Harald's Form 4 filing
Zai Lab Ltd (ZLAB) · filed Sep 8, 2021
- Accession no.
- 0001567619-21-016870
- Filed
- Sep 8, 2021
- Trade date
- Sep 7, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.51M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reinhart HaraldCIK 0001835824 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 | Ordinary Shares | MOption exerciseAcquired | +10,000 | $3.00 | +$30,000 | 10,000 | Direct | |
| Sep 7, 2021 | Ordinary Shares | SSaleDisposed | −100 | $143.00 | −$14,300 | 9,900 | Direct | |
| Sep 7, 2021 | Ordinary Shares | SSaleDisposed | −200 | $146.98F2 | −$29,396 | 9,700 | Direct | |
| Sep 7, 2021 | Ordinary Shares | SSaleDisposed | −300 | $148.69F3 | −$44,607 | 9,400 | Direct | |
| Sep 7, 2021 | Ordinary Shares | SSaleDisposed | −2,000 | $150.41F4 | −$300,820 | 7,400 | Direct | |
| Sep 7, 2021 | Ordinary Shares | SSaleDisposed | −6,600 | $151.28F5 | −$998,448 | 800 | Direct | |
| Sep 7, 2021 | Ordinary Shares | SSaleDisposed | −800 | $152.11F6 | −$121,688 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 | Ordinary Shares | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 23,334 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Reflects a weighted average sale price of $146.98 per share, at prices ranging from $146.66 to $147.30 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Reflects a weighted average sale price of $148.69 per share, at prices ranging from $148.23 to $148.92 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Reflects a weighted average sale price of $150.41 per share, at prices ranging from $149.80 to $150.78 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Reflects a weighted average sale price of $151.28 per share, at prices ranging from $150.84 to $151.82 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Reflects a weighted average sale price of $152.11 per share, at prices ranging from $151.85 to $152.50 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.